A Short-Term Quality of Life Study in Facial Synkinesis Patients: Selective Facial Neurectomy Combined with Chemodenervation Versus Chemodenervation Alone
Restricted accessResearch articleFirst published online 2026
A Short-Term Quality of Life Study in Facial Synkinesis Patients: Selective Facial Neurectomy Combined with Chemodenervation Versus Chemodenervation Alone
Guntinas-LichiusO, PrengelJ, CohenO, et al.Pathogenesis, diagnosis and therapy of facial synkinesis: A systematic review and clinical practice recommendations by the international head and neck scientific group. Front Neurol. 2022;13:1019554.
2.
NevilleC, VenablesV, AsletM, et al.An objective assessment of botulinum toxin type A injection in the treatment of post-facial palsy synkinesis and hyperkinesis using the synkinesis assessment questionnaire. J Plast Reconstr Aesthet Surg. 2017;70(11):1624–1628.
3.
ShtraksJP, MirochaJ, AzizzadehB. Quality of life outcomes after modified selective neurectomy for postfacial paralysis synkinesis. Facial Plast Surg Aesthet Med. 2021;23(6):443–448.
4.
AzizzadehB, IrvineLE, DielsJ, et al.Modified selective neurectomy for the treatment of post-facial paralysis synkinesis. Plast Reconstr Surg. 2019;143(5):1483–1496.
